Literature DB >> 30106236

Prediction of transplant outcome after 24-hour ex vivo lung perfusion using the Organ Care System in a porcine lung transplantation model.

Wiebke Sommer1, Jawad Salman1, Murat Avsar1, Klaus Hoeffler1, Katharina Jansson1, Thierry N Siemeni1, Ann-Kathrin Knoefel1, Linda Ahrens1, Reza Poyanmehr1, Igor Tudorache1, Peter Braubach2, Danny Jonigk2, Axel Haverich1, Gregor Warnecke1.   

Abstract

Ex vivo lung perfusion (EVLP) has become routine practice in lung transplantation. Still, running periods exceeding 12 hours have not been undertaken clinically to date, and it remains unclear how the perfusion solution for extended running periods should be composed and which parameters may predict outcomes. Twenty-four porcine lungs underwent EVLP for 24 hours using the Organ Care System (OCS). Lungs were ventilated and perfused with STEEN's solution enriched with erythrocytes (n = 8), acellular STEEN's solution (n = 8), or low-potassium dextran (LPD) solution enriched with erythrocytes (n = 8). After 24 hours, the left lungs were transplanted into recipient pigs. After clamping of the contralateral lung, the recipients were observed for 6 hours. The most favorable outcome was observed in organs utilizing STEEN solution enriched with erythrocytes as perfusate, whereas the least favorable outcome was seen with LPD solution enriched with erythrocytes for perfusion. Animals surviving the observation period showed lower peak airway pressure (PAWP) and pulmonary vascular resistance (PVR) during OCS preservation. The results suggest that transplantation of lungs following 24 hours of EVLP is feasible but dependent on the composition of the perfusate. PAWP and PVR during EVLP are early and late predictors of transplant outcome, respectively.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  basic (laboratory) research/science; lung failure/injury; lung transplantation/pulmonology; organ perfusion and preservation; organ procurement and allocation

Mesh:

Substances:

Year:  2018        PMID: 30106236     DOI: 10.1111/ajt.15075

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

Review 1.  Breathing lung transplantation with the Organ Care System (OCS) Lung: lessons learned and future implications.

Authors:  William Lightle; Daoud Daoud; Gabriel Loor
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

2.  Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs.

Authors:  Ahmed E Hozain; John D O'Neill; Matthew Bacchetta; Gordana Vunjak-Novakovic; Meghan R Pinezich; Yuliya Tipograf; Rachel Donocoff; Katherine M Cunningham; Andrew Tumen; Kenmond Fung; Rei Ukita; Michael T Simpson; Jonathan A Reimer; Edward C Ruiz; Dawn Queen; John W Stokes; Nancy L Cardwell; Jennifer Talackine; Jinho Kim; Hans-Willem Snoeck; Ya-Wen Chen; Alexander Romanov; Charles C Marboe; Adam D Griesemer; Brandon A Guenthart
Journal:  Nat Med       Date:  2020-07-13       Impact factor: 87.241

3.  Multiday maintenance of extracorporeal lungs using cross-circulation with conscious swine.

Authors:  Ahmed E Hozain; Yuliya Tipograf; Meghan R Pinezich; Katherine M Cunningham; Rachel Donocoff; Dawn Queen; Kenmond Fung; Charles C Marboe; Brandon A Guenthart; John D O'Neill; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-17       Impact factor: 6.439

4.  Ex vivo lung perfusion with perfusate purification for human donor lungs following prolonged cold storage.

Authors:  Dong Wei; Fei Gao; Zhenkun Yang; Wei Wang; Yinglun Chen; Yan Lu; Jingyu Chen
Journal:  Ann Transl Med       Date:  2020-02

Review 5.  Ischemia-Reperfusion Injury in Lung Transplantation.

Authors:  Toyofumi Fengshi Chen-Yoshikawa
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.